ArticleWorld journal of radiology2025
Predicting hematoma growth in spontaneous intracerebral hemorrhage: A simplified non-contrast computed tomography based five-point grading approach.
Article in World journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Combined application of the modified early warning score and the modified hematoma expansion prediction score for predicting hematoma expansion in intracerebral hemorrhage.Scientific reports · 2026Article
- Risk factors and development of a prediction model for hematoma expansion in elderly patients with spontaneous intracerebral hemorrhage.Frontiers in aging neuroscience · 2026Article
- A novel dose-dependent predictor for hematoma expansion on non-contrast CT: the number of black hole signs in spontaneous intracerebral hemorrhage.Neurosurgical review · 2025Article
- Toward rapid, practical risk stratification in spontaneous intracerebral hemorrhage.World journal of radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracerebral hemorrhage (ICH) comprises 9%-27% of stroke patients. Hematoma expansion (HE) occurs in approximately 20% of patients following ICH, typically within the first 24 hours. HE increases mortality and long-term disability in these patients and is being investigated as a therapeutic target to improve the outcome in these patients by limiting HE. Non-contrast computed tomography (NCCT) has potential in predicting HE, which can identify the individuals at risk.
aimTo evaluate NCCT markers for predicting HE in patients with ICH and to develop a simple, practical grading system for risk stratification.
methodsThis prospective observational study evaluated 192 patients with spontaneous ICH who underwent a baseline NCCT within four hours of admission, followed by a follow-up scan after six hours or earlier if there was clinical deterioration. Hematoma volumes and imaging characteristics that predicted HE were evaluated. A simple five-point grading system score was created to predict HE. In this scoring system, five imaging parameters were evaluated, with each parameter assigned a score of either 0 or 1. The parameters included: (1) Baseline hematoma volume ≥ 30 mL
resultsOf the 192 patients studied, HE was seen in 106 (55.2%). The mean baseline hematoma volume was significantly greater among patients in the HE group (44.1 mL) compared to those in the non-HE group (12.2 mL), with a
conclusionThe five variables demonstrated statistically significant associations with HE. This simple and practical 5-point prediction score can enable identification of patients at elevated risk of HE based on baseline NCCT findings. This can facilitate timely recognition of high-risk individuals who may benefit from targeted anti-expansion therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.